Davide Ramoni

MD, Internal Medicine specialist
PhD student (TaCIM) in joint supervision @UniGenova @USI_university
Science and football enthusiast

[Davide Ramoni @DavideRamoni]

🫀 Despite modern therapies, residual cardiovascular risk remains high.
JCAD emerges as a promising target to address residual CV risk in patients with acute coronary syndrome.
📖 Read our publication in European Heart Journal 🚀 @ehj_ed @escardio https://t.co/x5Qhtneo2G

[Inter ⭐⭐ @Inter]

Tanti auguri, Milito, Principe Nerazzurro 🖤💙

[European Society of Cardiology @escardio]

It's happening!
Early-career cardiovascular researchers from across the world are coming together for the first full-funded and hands-on ESC Fund Basic Cardiovascular Science Course.
From an intensive first week to placements in leading European labs, this course is building the next generation of scientists and strengthening cardiovascular research where it matters most.

This programme has been made possible thanks to ESC Fund and is generously supported by the Novo Nordisk Foundation, reinforcing a shared commitment to strengthening global cardiovascular research capacity.
@novonordiskfond

[Davide Ramoni @DavideRamoni]

The time is coming! 🚀
Excited to be among the 50 fellows joining the ESC Fund #BasicScienceCourse2026 in Nice 🇫🇷 Looking forward to learning from leading experts in cardiovascular research and connecting with scientists across Europe. Grateful to @escardio for this opportunity!

[Davide Ramoni @DavideRamoni]

Very good time in Lisbon for European Society for Clinical Investigation 2026 ASM 🇵🇹
Science, networking, collaboration, and a beautiful city to host it all. Looking forward to the next edition in Coimbra! 🔬

[Luca Liberale @liberale_luca]

Proud to be running for Chairperson Elect of the @escardio Working Group on Atherosclerosis & Vascular Biology. If you’re a member, your vote matters - and I’d be honored to have your support. Let’s keep pushing the science forward together. 🫀

[Simon Kraler @KralerSimon]

Check out our study with @liberale_luca on a novel therapeutic target for coronary artery disease: #JCAD

@CarboneF82 @DavideRamoni @HemostasisToday @escardio @TomLuscher @EHJACVCEiC @cescobruno @UZH_en

[Davide Ramoni @DavideRamoni]

🫀 A major avenue for cardiovascular research ahead.
JCAD emerges as a promising target to tackle residual cardiovascular risk in ACS patients.
📖 Read our publication in European Heart Journal
🔗 https://t.co/o9MSeWqDQB
#HeartHealth #Research #Cardiology

[EHJ Editor-in-Chief @ehj_ed]

Residual risk in acute coronary syndromes is increasigly debated. The junctional protein associated with coronary artery disease might play a relevant role according to a new study.
https://t.co/gNnlLAvZR0
#ACS #cardiotwitter, @ESC_Journals, @escardio

[EHJ Editor-in-Chief @ehj_ed]

Residual risk in acute coronary syndromes is increasigly debated. The junctional protein associated with coronary artery disease might play a relevant role according to a new study.
https://t.co/gNnlLAvZR0
#ACS #cardiotwitter, @ESC_Journals, @escardio

[Davide Ramoni @DavideRamoni]

@liberale_luca @KralerSimon 👏🏻

[Davide Ramoni @DavideRamoni]

🫀 Despite modern therapies, residual cardiovascular risk remains high.
JCAD emerges as a promising target to address residual CV risk in patients with acute coronary syndrome.
📖 Read our publication in European Heart Journal 🚀 @ehj_ed @escardio https://t.co/x5Qhtneo2G

[Davide Ramoni @DavideRamoni]

Joint symposium with the @escardio Council at the #SIC86 congress in Rome — promoting science, dialogue, and innovation to improve cardiovascular health in Europe.

[European Journal of Clinical Investigation @EJCI_News]

🔥An absolute must read!
EDITORIAL Wiley Online Library
Atrial fibrosis heterogeneity and atrial fibrillation risk in ischaemic heart failure
➡️ https://t.co/mX0kv4Won0
✍️AlessandroScuricini FabrizioMontecucco LucaLiberale AldoBonaventura FedericoCarbone Davide Ramoni
@UniGenova @SanMartino_Ge
@liberale_luca @CarboneF82 @aldobonaventura @DavideRamoni
#atrialfibrillation #atrialfibrosis #inflammation #ischaemicheartfailure

[ESCI @ESCI_Society]

A handful of our talented Abstract submitters. Stay in tune for the announcement of the winners!
View the Abstract submission supplement:
https://t.co/IO8rlJNVbd

#asm2025 #esci #abstracts

[Jamol Uzokov @jml_uz]

At #ESCI2025, the Cardiovascular Session on Acute Coronary Syndrome spotlights the next frontier: earlier diagnosis, smarter prevention, and precision interventions. Innovation is reshaping how we save lives. #ACS #CardioFuture #ESCI2025 @liberale_luca @ESCI_Society

[ESCI @ESCI_Society]

🛑Don’t miss this opportunity to stay ahead in basic/translational and clinical innovation.
ESCI2025 Annual Scientific Meeting
👉Register now https://t.co/pSVwRjQsGr
#mitochondria #cardiovascular #metabolichealth #oncology #rheumatology #focusonaging #gutliverlifestyle #ageing

[JACC Journals @JACCJournals]

🆕 2025 ACC/AHA/ACEP/NAEMSP/SCAI updated clinical guideline for the management of patients with #ACS just published! It incorporates new evidence and updated recommendations to improve #QoL and outcomes.

Get the details 👉 https://t.co/xTQGdiGRuy #cvACS #JACC #ClinicalGuidelines

[Davide Ramoni @DavideRamoni]

Join us in Genoa, May 21-23 2025 for the
@ESCI_Society Annual Meeting, co-organized by @liberale_luca and @carboneF82! 🔬

📢 Early bird registration and abstract submission deadline is extended until March 17! 🚀 #ESCI2025 #Research https://t.co/1XzjmuZ7MC

[Davide Ramoni @DavideRamoni]

@socios @FanTokens Done, forza Inter 🖤💙

[TimePie (focus on anti-aging science) @TimePieChina]

Roadmap for alleviating the manifestations of #aging in the cardiovascular system.
@liberale_luca, @SimonTualChalot @K_Stellos et al raise questions of the optimal design of clinical trials, in which markers of biological aging in humans could be assessed.
https://t.co/i1M2vxUKib

[Luca Liberale @liberale_luca]

🚨 Exciting News! 🚨

Join us in Genoa, May 2025 for the @ESCI_Society Annual Meeting, co-organized by @carboneF82 & me! 🌍🔬

📢 Early bird registration is now OPEN & abstract submission is live!

🔗 More info & registration: https://t.co/8eEv7mwybf

🧵👇 Why you should attend?